Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Denali Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rezolute Inc. November 19, 202581.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 16, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +28,895 | — | — |
| Mar 2, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −10,539 | $22.80 | $240,289 |
| Mar 1, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +11,643 | — | — |
| Nov 19, 2025 | Rezolute Inc. | Grant or award | +21,000 | — | — |
| Mar 3, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −15,103 | $42.10 | $635,836 |
| Mar 1, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +16,813 | — | — |
| Mar 1, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +18,443 | — | — |
| May 31, 2024 | Denali Therapeutics Inc. | Grant or award | +5,967 | — | — |
| Mar 1, 2024 | Ultragenyx Pharmaceutical Inc. | Grant or award | +19,400 | — | — |
| Mar 1, 2024 | Ultragenyx Pharmaceutical Inc. | Grant or award | +957 | — | — |
| Mar 1, 2024 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −4,768 | $53.76 | $256,328 |
| Sep 5, 2023 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −6,000 | $37.96 | $227,760 |
| Jun 19, 2023 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −305 | $48.20 | $14,701 |
| Jun 1, 2023 | Denali Therapeutics Inc. | Grant or award | +4,216 | — | — |
Questions about Erik Harris
What boards is Erik Harris on?
Erik Harris sits on the boards of Denali Therapeutics Inc. and Rezolute Inc.
How long has Erik Harris served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.